The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admission and enteral nutritional support by nasogastric tube. As well as the effect on metabolic control, development of comorbidities, hospital stay, readmissions, mortality and tolerance of the formula under study.

MAIN GOAL:

To evaluate the effect on the development of hyperglycemia diagnosed as glycemia> 126 mg / dl on an empty stomach or> 150 mg / dl during the infusion of enteral nutrition determined by capillary glycemia during the admission of a specific formula in patients with a first episode of ischemic stroke or hemorrhagic entry into the non-diabetic HCUV stroke unit requiring enteral nutrition by nasogastric tube.

Inclusion Criteria:

• Admitted for a first episode of ischemic or hemorrhagic stroke.
• Requiring total enteral nutrition by tube for at least 7 days

Exclusion Criteria:

• Contraindication to enteral nutrition
• Diabetes Mellitus
• Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting, abdominal pain
• Need for admission to the ICU
• Previous neurodegenerative disease
• Antibiotherapy for 7 days prior to the inclusion visit
• Allergies or intolerances to any of the components of the formula under study
• Pregnant patients

cover label